ウイルス抗原市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00017334
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 200
Buy Now

ウイルス抗原市場は、2019 年に 1 億 141 万米ドルと評価され、2027 年までに 2 億 3,680 万米ドルに達すると予測されています。 2020 年から 2027 年にかけて CAGR 11.0% で成長すると予想されています。



ウイルスは、植物や動物から古細菌や細菌に至るまで、あらゆる種類の生命体に感染する可能性があります。ウイルス抗原は、これらの毒性実体によって投与される毒または有毒物質であり、宿主に免疫反応を誘発します。例えば、ウイルス抗原は、骨髄または血液からの好中球および血小板中のIFAによって、または血清、唾液、涙、または血漿中のELISAによって決定されます。核酸増幅検査は、感染の段階を決定するために使用することもできます。血液検査または血清によって抗原を測定すると、最良の結果が得られます。



ウイルスは、植物や動物から古細菌や細菌に至るまで、あらゆる種類の生命体に感染する可能性があります。ウイルス抗原は、ウイルスによって投与され、宿主に免疫反応を誘発する毒または有毒物質です。ウイルスタンパク質は、ウイルスゲノムによって特定される抗原であり、特定の免疫学的応答を通じて認識できます。ウイルス抗原は、骨髄または血液からの好中球および血小板中の IFA によって、または血清、唾液、涙液、または血漿中の ELISA によって決定されます。核酸増幅検査は、感染の段階を決定するために使用することもできます。血液検査または血清を通じて抗原を測定すると、最良の結果が得られます。



ウイルス抗原市場の収益性の高い地域



市場洞察



ウイルス抗原の受け入れの増加ワクチン開発が市場の成長を促進 ウイルス抗原は、ウイルスによって放出される毒素またはその他の物質であり、宿主生物内で免疫応答(抗体を生成する)を誘導することができます。ウイルスタンパク質は、特定の免疫学的応答によって認識できるウイルスゲノム特異的抗原です。ワクチン接種は、感染性病原体が侵入した場合に病気を防ぐ免疫を宿主に確立することを目的としています。したがって、最も単純な形では、ウイルス性疾患のワクチン開発には、ウイルス特異的中和抗体を誘導し、オフターゲット抗体の誘導を回避する抗原の配布が含まれます。



ワクチンの開発と使用は、大きく進歩しました。病気や病気の数は年々減少しました。さまざまな新しいタイプのワクチンの導入は、DNA、RNA、タンパク質、糖の操作、免疫応答に関する知識の増加、遺伝子工学の大きな進歩によって可能になりました。弱毒化変異体の開発、生ベクターでの可能性のある抗原の発現、新しいシステムでの抗原の精製と直接合成により、ワクチン技術が大幅に強化されました。



製品インサイトコンポーネントの観点からは、コロナウイルス抗原セグメントが最大の地位を占めました。



ウイルス抗原市場、コンポーネント別 - 2019 年および 2027 年



ウイルス抗原市場、コンポーネント別 - 2019 年



h3>

Application Insights



世界のウイルス抗原市場は、エンドユーザーに基づいて、病院、診療所、研究所、診断センター、血液銀行、研究機関に分割されています。 2019 年には診断センター部門が市場で最大のシェアを占め、検査室市場は予測期間中に最高の CAGR で成長すると予想されています。



検査室は臨床検体検査が行われる場所です。病気の診断、治療、予防に役立てるために患者の健康に関する情報を収集するために実施されます。過去数十年にわたり、ウイルス診断研究所のサービスと患者の臨床管理における役割には大きな革命が起きました。研究室は規模も洗練度も異なり、幅広い研究設備を備えています。急性期病院や医療センターでは、より広範なサービスが提供される可能性があり、臨床判断の 70% は臨床検査に基づいています。診療所や診療所、専門看護施設や長期介護施設には、より基本的な検査サービスを提供する検査室がある場合があります。ウイルスを正確に診断するには、ウイルス抗原、ウイルス、または特異的抗体の存在についての臨床検体の検査が必要です。過去数十年にわたり、ウイルス診断検査機関のサービスと患者の臨床管理における役割には大きな革命が起きました。



戦略的洞察



ウイルス抗原市場で活動するプレーヤー技術的に高度な製品の導入を通じてエンドユーザーの要求を満たすコラボレーションおよびパートナーシップ戦略を採用し、これらの戦略が市場の成長を大きくサポートします。



コンポーネント別




  • インフルエンザウイルス抗原

  • コロナウイルス抗原

  • ジカウイルス抗原

  • エボラウイルス抗原

  • デング熱ウイルス抗原

  • 単純ヘルペスウイルス(HSV)ウイルス抗原

  • ロタウイルスウイルス抗原

  • AE型肝炎ウイルス抗原

  • 麻疹ウイルス抗原

  • おたふく風邪/耳下腺炎ウイルス抗原< /li>
  • その他


技術別




  • ELISA

  • 免疫測定法

  • 血球凝集

  • >
  • ラジオイムノアッセイ (RIA)

  • 免疫ペルオキシダーゼ染色

  • 免疫蛍光

  • その他


エンドユーザーによる


  • 病院

  • クリニック

  • 研究所

  • 診断センター

  • 血液銀行

  • 研究研究機関


地理別




  • 北アメリカ

    • 米国

    • カナダ

    • メキシコ< /li>


  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • ロシア



  • アジア太平洋

    • 中国

    • インド

    • 韓国

    • < li>日本
    • オーストラリア



  • 中東およびアフリカ

    • 南アフリカ

    • サウジアラビア

    • >
    • アラブ首長国連邦



  • 中南米

    • ブラジル

    • アルゼンチン



会社概要




  • Microbix Biosystems

  • BIO-RAD LABORATORIES INC.

  • Creative Diagnostics

  • >Aalto Bio Reagents Ltd.

  • Advanced Biotechnologies Inc.

  • Prospec-Tany Technogene Ltd.

  • ACROBiosystems.

  • MERIDIAN BIOSCIENCE, INC. .

  • Rekom Biotech SL

  • LGC Limited


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the viral antigens?

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

What are the driving factors for the viral antigens market across the globe?

The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.

What are the restraining factors for the viral antigens market across the globe?

The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.

The List of Companies - Viral Antigens Market

  1. Microbix Biosystems
  2. BIO-RAD LABORATORIES INC.
  3. Creative Diagnostics
  4. Aalto Bio Reagents Ltd.
  5. Advanced Biotechnologies Inc.
  6. Prospec-Tany Technogene Ltd.
  7. ACROBiosystems.
  8. MERIDIAN BIOSCIENCE, INC.
  9. Rekom Biotech S.L
  10.  LGC Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports